Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Our New Resource Page for Klatskin Tumour (Hilar Cholangiocarcinoma)

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | Mar 15, 2025

Klatskin tumour, also known as hilar cholangiocarcinoma, is a rare bile duct cancer that develops where the bile ducts meet outside the liver. The bile ducts transport bile from the liver to the small intestine, aiding digestion.

Klatskin tumour is a rare condition, affecting approximately 1 in 100,000 people, predominantly occurring in older adults aged 50 to 70, with men being slightly more affected than women.

Many sufferers of hilar cholangiocarcinoma struggle because they feel that their disease doesn’t have the same level of awareness as more common cancers. Without a Ribbon is an Australian non-profit organisation that believes that rare cancers should never go unnoticed. We aim to provide a detailed set of resources and information for anyone suffering from cancers such as hilar cholangiocarcinoma. We have recently created an hilar cholangiocarcinoma resource page to help sufferers understand their disease. It covers the symptoms, available treatments and other important information.

We hope that this resource page will help you or a friend/family member to learn about their illness and aid them through their battle with the disease.

If you want to help make a difference for sufferers of hilar cholangiocarcinoma, click here to learn how you can help!

Click the link below to read our resource page on hilar cholangiocarcinoma:

 

View hilar cholangiocarcinoma Resource Page

Share:

PreviousKlatskin Tumour (Hilar Cholangiocarcinoma)
NextGranulomatous Slack Skin (GSS)

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter